Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $83,290 | 42 | 88.8% |
| Food and Beverage | $10,282 | 596 | 11.0% |
| Education | $234.16 | 12 | 0.2% |
| Travel and Lodging | $25.00 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Shire North American Group Inc | $37,002 | 50 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $23,715 | 31 | $0 (2024) |
| GENZYME CORPORATION | $13,265 | 26 | $0 (2024) |
| ABBVIE INC. | $11,514 | 26 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,255 | 103 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $1,230 | 35 | $0 (2024) |
| CSL Behring | $1,064 | 73 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $980.55 | 61 | $0 (2024) |
| PFIZER INC. | $599.04 | 44 | $0 (2024) |
| Pharming Healthcare, Inc. | $398.93 | 24 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,715 | 57 | ABBVIE INC. ($3,816) |
| 2023 | $14,901 | 25 | Takeda Pharmaceuticals U.S.A., Inc. ($7,692) |
| 2022 | $12,890 | 129 | Takeda Pharmaceuticals U.S.A., Inc. ($10,610) |
| 2021 | $8,173 | 118 | GENZYME CORPORATION ($3,859) |
| 2020 | $6,564 | 80 | Takeda Pharmaceuticals U.S.A., Inc. ($3,115) |
| 2019 | $17,754 | 83 | Shire North American Group Inc ($10,113) |
| 2018 | $8,913 | 71 | Shire North American Group Inc ($8,010) |
| 2017 | $19,922 | 88 | Shire North American Group Inc ($18,879) |
All Payment Transactions
651 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: Respiratory | ||||||
| 12/14/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: Immunology | ||||||
| 12/09/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: Respiratory | ||||||
| 12/05/2024 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Inflammation & Immunology | ||||||
| 12/02/2024 | CSL Behring | Haegarda (Biological) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Immunology | ||||||
| 11/21/2024 | BioCryst US Sales Co., LLC | ORLADEYO (Drug) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: Immunology | ||||||
| 11/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: RESPIRATORY | ||||||
| 11/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: Respiratory | ||||||
| 11/11/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: Inflammation | ||||||
| 11/07/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: Immunology | ||||||
| 10/31/2024 | Pharming Healthcare, Inc. | RUCONEST (Biological) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: BIOLOGIC | ||||||
| 10/28/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: Immunology | ||||||
| 10/24/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Immunology | ||||||
| 10/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Immunology | ||||||
| 10/14/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Inflammation | ||||||
| 10/10/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 10/07/2024 | Cycle Pharmaceuticals Inc | Sajazir (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: IMMUNOLOGY | ||||||
| 10/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,350.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/03/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: Immunology | ||||||
| 09/30/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Immunology | ||||||
| 09/26/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: Immunology | ||||||
| 09/23/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $15.88 | General |
| Category: Dermatology | ||||||
| 09/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 62 | 89 | $23,855 | $6,090 |
| 2022 | 5 | 124 | 497 | $44,045 | $10,936 |
| 2021 | 7 | 170 | 405 | $66,330 | $16,916 |
| 2020 | 7 | 156 | 1,228 | $78,465 | $20,702 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 22 | 32 | $12,220 | $2,927 | 24.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 26 | 32 | $8,260 | $2,437 | 29.5% |
| 94375 | Test to measure rate of airflow | Office | 2023 | 14 | 25 | $3,375 | $726.39 | 21.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 32 | 37 | $13,320 | $4,034 | 30.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 41 | 49 | $12,005 | $3,167 | 26.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 17 | 17 | $6,120 | $1,508 | 24.6% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 13 | 369 | $9,225 | $1,411 | 15.3% |
| 94375 | Test to measure rate of airflow | Office | 2022 | 21 | 25 | $3,375 | $816.03 | 24.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 55 | 74 | $18,130 | $5,160 | 28.5% |
| 95018 | Allergy testing with drugs or biologicals into or within the skin, immediate type reaction, including test interpretation and report | Office | 2021 | 22 | 178 | $16,870 | $3,451 | 20.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 21 | 21 | $11,550 | $3,004 | 26.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 24 | 25 | $9,000 | $2,826 | 31.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 15 | 15 | $5,400 | $1,283 | 23.8% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2021 | 20 | 24 | $3,000 | $609.82 | 20.3% |
| 95117 | Injection of incremental dosages of allergen, 2 or more injections | Office | 2021 | 13 | 68 | $2,380 | $581.90 | 24.4% |
| 95165 | Preparation and provision of single or multiple antigens for allergen immunotherapy | Office | 2020 | 14 | 687 | $30,915 | $9,470 | 30.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 31 | 37 | $13,320 | $3,410 | 25.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 43 | 50 | $12,250 | $2,853 | 23.3% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 14 | 14 | $7,700 | $2,064 | 26.8% |
| 95004 | Injection of allergenic extracts into skin, accessed through the skin | Office | 2020 | 12 | 337 | $8,425 | $1,367 | 16.2% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2020 | 24 | 25 | $3,125 | $790.12 | 25.3% |
| 95117 | Injection of incremental dosages of allergen, 2 or more injections | Office | 2020 | 18 | 78 | $2,730 | $748.06 | 27.4% |
About Dr. Mark Weinstein, M.D
Dr. Mark Weinstein, M.D is a Pediatrics healthcare provider based in Belleville, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/14/2007. The National Provider Identifier (NPI) number assigned to this provider is 1528274040.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Weinstein, M.D has received a total of $93,831 in payments from pharmaceutical and medical device companies, with $4,715 received in 2024. These payments were reported across 651 transactions from 37 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($83,290).
As a Medicare-enrolled provider, Weinstein has provided services to 512 Medicare beneficiaries, totaling 2,219 services with total Medicare billing of $54,644. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty Pediatrics
- Other Specialties Allergy & Immunology
- Location Belleville, NJ
- Active Since 05/14/2007
- Last Updated 05/27/2025
- Taxonomy Code 208000000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1528274040
Products in Payments
- CINRYZE (Drug) $60,121
- RINVOQ (Biological) $11,514
- DUPIXENT (Biological) $7,769
- DUPIXENT (Drug) $6,710
- NUCALA (Biological) $721.69
- Haegarda (Biological) $670.24
- TRELEGY ELLIPTA (Drug) $443.98
- RUCONEST (Biological) $398.93
- TEZSPIRE (Biological) $356.87
- Hizentra (Biological) $345.82
- TAKHZYRO (Biological) $337.27
- Xolair (Biological) $332.97
- EUCRISA (Drug) $325.83
- CUTAQUIG (Biological) $307.96
- FASENRA (Biological) $265.05
- FASENRA (Drug) $225.13
- CUVITRU (Biological) $222.30
- ALVESCO (Drug) $221.86
- AUVI-Q (Drug) $168.23
- Xhance (Drug) $151.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Belleville
Mrs. Bernadette Sobczak, Dnp, Aprn, Cpnp-Pc,, DNP, APRN, CPNP-PC,
Pediatrics — Payments: $1,800
Mrs. Judith Meek, Cpnp, CPNP
Pediatrics — Payments: $1,353
David Norman, Md, MD
Pediatrics — Payments: $1,322
Dr. Dalia Pando, Md, MD
Pediatrics — Payments: $1,297
Dr. Gloria Okoh, M.d, M.D
Pediatrics — Payments: $933.80
Dr. Robert Quaas, M.d, M.D
Pediatrics — Payments: $564.50